Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study.

Palak J TrivediKatherine ArndtzNadir AbbasAlison TelfordLiam YoungRajarshi BanerjeePeter EddowesKartik S JhaveriGideon M Hirschfield

Published in: Alimentary pharmacology & therapeutics (2024)

Quantitative MRCP+ identifies changes in ductal disease over time in PSC, despite stability in biochemistry, liver stiffness and radiologist-derived cholangiographic assessment (trial registration: ISRCTN39463479).

Keyphrases

high resolution
clinical trial
study protocol
genome wide
randomized controlled trial
phase iii
gene expression
dna methylation
open label